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C62B rat glioma cells respond to muscarinic cholin- 
ergic stimulation with  transient inositol phosphate for- 
mation and phospholipase Az-dependent arachidonic 
acid liberation. Since phospholipase Az is  a Caz+-sen- 
sitive enzyme, we have examined the role of the ago- 
nist-stimulated Ca2+ response in production of the ar- 
achidonate signal. The fluorescent indicator fura-2 
was used to monitor changes in cytoplasmic Ca2+ levels 
([Ca2+Ii) of C62B cells following acetylcholine treat- 
ment. In  the presence of extracellular Ca2+, acetylcho- 
line induces a biphasic [Ca”+]i response consisting of an 
initial  transient peak that precedes arachidonate lib- 
eration and a sustained elevation that outlasts  the phos- 
pholipase Az response. The  initial [Caz+]i peak is not 
altered by the absence of external Ca2+ and  therefore 
reflects  intracellular Ca2+ mobilization. The sustained 
elevation phase is dependent on the  influx of external 
Ca2+; it  is lost in Caz+-free medium and  restored on the 
addition of Ca2+. Pretreating cells with phorbol dibu- 
tyrate substantially  inhibits acetylcholine-stimulated 
inositol phosphate formation and  the peak [Ca2+]i re- 
sponse without affecting the sustained elevation in 
[Caz+li. This suggests that  the release of internal Caz+ 
stores by inositol 1,4,5-trisphosphate can be blocked 
without interfering with Ca2+ influx. Pretreatment 
with phorbol also fails  to affect acetylcholine-stimu- 
lated  arachidonate  liberation,  demonstrating that 
phospholipase AZ activation does  not require normal 
intracellular Caz+ release. Stimulated arachidonate ac- 
cumulation is totally inhibited in Ca2+-free medium and 
restored by the subsequent addition of Ca2+. Pretreat- 
ment with verapamil, a voltage-dependent Ca2+ chan- 
nel inhibitor, also blocks both the sustained [Ca2+Ii 
elevation and  arachidonate  liberation without altering 
peak intracellular Caz+ release. We conclude that  the 
influx of extracellular Ca2+ is  tightly coupled to phos- 
pholipase Az activation, whereas large changes in 
[Ca2+]i due to mobilization of internal Ca2+ stores  are 
neither sufficient nor necessary for acetylcholine-stim- 
ulated phospholipase Az activation. 
A wide variety of tissues respond to hormone and neuro- 
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transmitter binding with  stimulated phospholipase C-depend- 
ent hydrolysis of phosphatidylinositol 4,5-bisphosphate 
(PIP2)’ (reviewed in 1-3). PIPz cleavage produces inositol 
1,4,5-trisphosphate (1,4,5-IPS), which increases cytoplasmic 
calcium levels ([Ca2+Ji) by binding to specific intracellular 
receptors and mobilizing sequestered Cap+ stores (41, and 
diacylglycerol, which activates  protein kinase C (5). An influx 
of extracellular Ca2+ is also stimulated by one or more possible 
mechanisms (3, 6, 7). 
In many cases, agonist-stimulated PIPp hydrolysis is accom- 
panied by phospholipase A2 activation, with consequent lib- 
eration of free arachidonic acid from cellular phospholipid 
and generation of eicosanoid second messengers (2). Although 
phospholipase C is generally believed to be under the direct 
control of one or more guanine nucleotide-binding proteins 
(G proteins) (8, 9), the mechanism for phospholipase A2 
regulation is less certain. G proteins may play a role in 
phospholipase Ap control (lO-lZ), but many other cellular 
factors are capable of modulating the enzyme’s activity as 
well, including Ca2+ (13, 14), diacylglycerol (15), protein ki- 
nase C (16-19), inhibitory  proteins  (lipocortins) (20, 21), and 
Na’/H’ exhange (22). The physiological significance of all 
these (not mutually exclusive) factors is unclear, however. 
Cytoplasmic Cap+ levels have long been proposed as a 
primary in uiuo regulator of phospholipase A2 activity (1, 13, 
14). Purified phospholipase AP enzymes generally show a 
positive correlation between in vitro activity and Cap+  concen- 
trations above basal physiological [Ca2+Ii (23-26), and  at least 
one isolated enzyme shows complete activation by Cap+ over 
a  stimulated in uiuo [Ca2+]i range (24). Further evidence has 
come from studies using Cap+ ionophores or detergents to 
manipulate [Cap+]; in “intact” cells; the use of millimolar 
external Cap+ with ionophores produces phospholipase A2 
activation in many cell types (2, 17, 27, 28), including C62B 
cells (29). Arachidonate liberation has been observed in glo- 
merular mesangial cells and platelets with controlled increases 
in [Ca2+]i over the physiological agonist-stimulated range (19, 
30). 
Previous work in this laboratory has demonstrated that 
C62B rat glioma cells respond to muscarinic stimulation with 
rapid inositol phosphate formation followed by a transient 
accumulation of arachidonate peaking at  60-90 s (29, 31). In 
’ The abbreviations used are: PIP,, phosphatidylinositol 4,5-bis- 
phosphate; BME, basal medium Eagle’s; [Ca’+],, cytoplasmic free 
calcium concentration; EGTA, [ethylenebis(oxyethylenenitrilo)]tet- 
raacetic acid; G  protein, guanine nucleotide-binding protein; HBSS, 
Hanks’ balanced salt solution; HEPES, N-2-hydroxyethylpiperazine- 
N’-2-ethanesulfonic acid  HPLC, high performance liquid chroma- 
tography; 1,4,5-IP3, inositol 1,4,5-trisphosphate; PDBu, phorbol 
12,13-dibutyrate. 
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this system, arachidonate liberation occurs preferentially via 
phospholipase Az degradation of phosphatidylinositol (31). 
The present study was conducted to determine the relative 
roles of intracellular Ca2+ mobilization and extracellular Ca2+ 
influx in cholinergically stimulated phospholipase Az activa- 
tion in these cells. 
EXPERIMENTAL PROCEDURES 
Materials 
Basal medium Eagle's (BME) was purchased from GIBCO. Fetal 
calf serum was from Flow Laboratories (McLean, VA). Fura-2/AM 
and ionomycin were obtained from Calbiochem. [1-"CIArachidonic 
acid (58 mCi/mmol) and my0-[2-~H]inositol (18.7 Ci/mmol) were 
from  Amersham Corp. Acetylcholine, phorbol 12,13-dibutyrate 
(PDBu), and verapamil were  from Sigma. The  Partisill0 SAX anion 
exchange high performance liquid chromatography (HPLC) column 
(4.5 X 25 cm) and Silica Gel LK6D thin layer chromatography (TLC) 
plates were purchased from Whatman  (Maidstone, United Kingdom). 
All other materials were reagent grade. 
Methods 
Cell Culture"C62B cells were cultured in BME supplemented with 
5% fetal calf serum, 1 mM glucose, 2 mM L-glutamine, 50 units/ml 
penicillin, and 50 pg/ml streptomycin in a humidified environment 
of 5%  C02  and 95% air at 37 "C. The cells were  grown to confluence 
in 75-cm2 Corning culture flasks and harvested by trypsinization as 
described previously (29); the only modification was the use of a 
calcium-free medium (11 mM glucose, 20 mM HEPES, 10.2 mM 
trisodium citrate,  4 mM potassium chloride, 110 mM sodium chloride, 
pH 7.2)  for harvesting. 
Cytoplasmic Ca2+ Measurement-Aliquots of harvested cells were 
allowed to settle onto sterile glass coverslips in 100-mm Corning 
tissue culture dishes, and  the cells were  grown to confluence over 2- 
10 days in supplemented BME as described above. Coverslips were 
mounted into a chamber and washed three times with unsupple- 
mented BME, and  the attached cells were incubated with 5 /IM fura- 
2/AM in BME  for  17  min at 37 "C. The cells were washed three times 
with Hanks' balanced salt solution (HBSS, containing 137 mM so- 
dium chloride, 5.4 mM potassium chloride, 0.8 mM magnesium sulfate, 
0.4 mM sodium phosphate dibasic, 0.4 mM potassium phosphate 
monobasic, 5.6 mM glucose, 1.3 mM calcium chloride, pH 7.2) prior 
to measurement of fura-2 fluorescence. Fura-2 loading under  these 
conditions produced a diffuse fluorescence with no visible intracel- 
lular localization of the dye. 
Epifluorescence microscopy (32) was  used to monitor changes in 
the fura-2 fluorescence of the C62B  cell monolayer. The chamber was 
mounted on an inverted Nikon Diaphot-TMD microscope, and a 
Fluor 40 X objective  was  used to examine 12-25 cells at a given time. 
Fura-2 fluorescence was recorded at  1-s intervals using a dual exci- 
tation wavelength spectrofluorometer (Spex Industries, Edison, NJ) 
with excitation at 340 and 380 nm and emission at 500 nm. All 
experiments were performed in either the Ca'+/MgZ+-containing 
HBSS described above  or in HBSS without added Ca2+ or M%+ and 
with 0.5 mM EGTA. Experiments were conducted at room tempera- 
ture since the Ca2+ response was found to be identical at room 
temperature  and 37 "C, but the higher temperature greatly accelerated 
dye leakage. Cells  were treated with acetylcholine (2.75  mM) or drugs 
by the addition of 4-10 X concentrates to obtain the desired final 
concentration. PDBu and verapamil were added as ethanolic solutions 
of HBSS 20-30 min prior to acetylcholine stimulation; solvent con- 
centrations, which never exceeded 0.5%, had no effect on the fura-2- 
monitored Ca2+ response. After stimulation, the cells were rinsed free 
of agonist by  10-12 media changes and were  given 20 min to recover 
prior to restimulation. Media changes and additions of agonist or 
drugs were  made without an interruption in recording. In some 
experiments, the initial acetylcholine-stimulated Ca'+ response varied 
slightly from all subsequent control responses, perhaps due to incom- 
plete dye hydrolysis or a  transient buffering effect (32, 33); in such 
cases, the initial response was discarded. 
The free intracellular Ca2+ concentration ([Ca*+],) was calculated 
from the ratio of the fluorescence intensities at  the two excitation 
wavelengths as described by Grynkiewicz et al. (34) using a K d  of 224 
nM for the fura-2. Ca" complex. The minimum and maximum ratios 
were determined for the cells at  the end of each experiment using 10 
p~ ionomycin; R,,, was obtained by equilibration with 2.5 mM EGTA 
in a depolarizing medium (130 mM potassium chloride, 20 mM sodium 
chloride, 10 mM HEPES, 1 mM magnesium chloride, pH 7.2), and 
R,,, was then found by the readdition of Ca'+ in the same medium 
until  the  fura-2 signal reached saturation. The excitation spectrum 
of the cellular fura-2 under these conditions was similar to  that of 
free fura-2 in the same solutions. Background autofluorescence, de- 
termined by the subsequent addition of 1 mM manganese sulfate to 
the permeabilized cells, was subtracted from the 340 and 380 nm 
traces prior to calculating [Ca'+];. 
Labeling Cells with  P'CIArachidonic  Acid and rH]Znositol-Sterile 
glass scintillation vials were exposed to 1.5 ml of poly-D-lysine (10 
pg/ml) for 20 min and allowed to air dry. C62B cells were  seeded into 
the vials as described previously (29). The cultures were then incu- 
bated for 18-24 h, the medium was  removed by aspiration, and cells 
were labeled by incubation for 24 h in 0.75 ml of fresh medium 
containing 0.2 pCi of [ 1-"Clarachidonic acid. In some cases, 25  pCi 
of my0-[2-~H]inositol was also included (31). 
Assays for Arachidonic Acid Liberation and Inositol Phosphte 
Formation-These assays were conducted following protocols de- 
scribed previously (29,31). Briefly, the labeling medium  was  removed, 
the cultures were rinsed, fresh medium was added, and  the cells were 
placed in  a 37 "C water bath. BME containing 30 mM HEPES, pH 
7.2, was used for arachidonate experiments, whereas double-label 
experiments were performed using CaZ+/Mg2f-containing HBSS (15 
mM HEPES, pH 7.2) with 25 mM lithium chloride. Drugs were added 
in 50-pl aliquots to give the desired final  concentrations in a  total 
volume of  0.75  ml. PDBu and verapamil were made up in the appro- 
priate medium and added as described above; solvent concentrations 
used had  no effect on stimulated  arachidonate liberation or inositol 
phosphate formation. Incubations were carried out  in the 37 "C water 
bath for the times indicated and were terminated by the addition of 
2.8 ml of chloroform/methanol/hydrochloric acid (v/v/v, 100:200:2) 
followed by agitation in a sonicating water bath. Cell extracts were 
transferred to centrifuge tubes, 0.9 ml of water and 0.9 ml of chloro- 
form were added, and  the tubes were agitated on a Vortex shaker. 
The tubes were kept overnight at 0 "C, and  the phases were separated 
by centrifugation. 
Separation of lipids was performed by evaporating the organic 
phases under a  stream of nitrogen, redissolving the residues in 50 pl 
of chloroform, and applying 20-p1 portions to LKGD TLC plates. 
Arachidonic acid  was separated from esterified lipids using a solvent 
system consisting of the upper phase of a  mixture of ethyl  acetate/ 
isooctane/acetic acid/water (v/v/v/v, 93:47:20:100) as reported pre- 
viously (29). Radiolabeled species were visualized by autoradiography 
using Kodak XAR  film and quantitated by scraping portions of the 
silica gel into scintillation vials followed by liquid scintillation spec- 
trometry. 
Inositol phosphates were separated  in [3H]inositol-labeling exper- 
iments by anion exchange chromatography using HPLC or Dowex 
AG 1-X8 resin. For HPLC analysis (35), the aqueous phases were 
evaporated to 1 ml under  a  stream of nitrogen, diluted to 4 ml with 
water, and applied to a  Partisil 10 SAX analytical HPLC column. 
The column was washed with 20  ml  of water to remove free inositol, 
and inositol phosphates were eluted using a 70-min linear gradient of 
0-1.5 M ammonium formate, pH 3.7, with a flow rate of 1 ml/min 
and 1-ml fractions collected. The radioactivity present  in the eluent 
was quantitated by liquid scintillation spectrometry. Peaks of radio- 
activity were identified by coelution with radiolabeled standards. 
Dowex chromatography (36) was carried out using an ammonium 
formate step gradient as described previously (37). 
Statistical Analysis-The data are presented as the mean k S.E. of 
the indicated number of experiments. Statistical differences between 
control and treated values were analyzed using a t test for Ca2+ 
experiments and a one-way ANOVA with Tukey's Studentized range 
test for arachidonate studies. 
RESULTS 
Acetylcholine Stimulation Produces a Biphasic  Response in 
Cytoplasmic  Calcium Levels-Previous  work in this laboratory 
has demonstrated that acetylcholine stimulation of rnusca- 
rinic receptors produces phospholipase C  activation and 1,4,5- 
IPS formation in C62B cells (31). The fluorescent Ca2+ dye 
fura-2 (34) was used to characterize associated changes in 
[Ca2+Ii (Fig. 1). Acetylcholine produces a biphasic [Ca2+]i 
response in the presence of external Ca2+. Basal [Caz+]i, 26 +. 
4 nM, increases to a peak value of 420 * 54 nM (n = 19) 
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FIG.  1. Acetylcholine-stimulated  changes  in  fura-2  fluores- 
cence and [CaZ+li in the presence of 1.3 mM external Ca2'. 
C62R cells  loaded  with  fura-2  were  stimulated  with 2.i5 mM acetyl- 
choline ( A C h ) ,  and  the  changes  in  fluorescence  were  recorded  using 
a dual excitation wavelength spectrofluorometer with excitation at 
340 and 380 nm, as described  under  "Methods." Panel A shows  the 
ratio of the fluorescence intensities at these two wavelengths in a 
trpical  experiment  after  the  addition of  agonist  and 10 pM atropine 
at the times indicated. In panel R, calculated [Ca'+], values from 
multiple  experiments  are  shown  at  various  points  in  the  stimulated 
response, either prior to acetylcholine addition ( p r e ) ,  at the peak 
ratio intensity ( p e a k ) ,  or at  1, 2, 3, 4, or 5 min after acetylcholine 
addition. Data shown are the average +. S.E. of mean control re- 
sponses in 17-19 separate  experiments. 
within  10 s of agonist  addition,  consistent  with  the  previously 
determined  time  course of 1,4,5-IPS  formation (31). A rapid 
drop  in [Ca'+],, which lasts about 1 min,  is  followed  by a more 
gradual  decline  to a sustained  plateau of approximately  100 
nM, which  can  last at least 20  min  in  the  continued  presence 
of agonist  (not  shown).  Addition of the  muscarinic  receptor 
antagonist atropine at any time rapidly returns [Ca'+], to 
basal levels (Fig. 1). Acetylcholine was used at a saturating 
concentration of 2.75 mM to  facilitate  comparison of results 
with  previous  biochemical  studies  (29,  31,  37, 38). The  iden- 
tical  dose-response  curves  for  phospholipase  C  and  phospho- 
lipase A? activation  rule  out  the  use of agonist  concentration 
for  separating  the  two  responses  (29). 
Removing  Extracellular Ca2+ Block  the Second  Phase  of  the 
[Ca"], Response without Affecting the Initial Peak-Acetyl- 
choline-stimulated  changes  in [Ca"], were  examined  in Ca"- 
free  medium  to  dissect  the  contributions of intracellular  and 
extracellular Ca" pools. Ca"-containing medium was aspi- 
rated  away  from  fura-2-loaded  C62B  cells  and  replaced  with 
Ca'+-free  medium  with 0.5 mM EGTA;  agonist  was  then  added 
within  30 s (Fig.  2).  This  produced a slight  lowering of basal 
[Ca'+], but failed to affect the initial peak [Ca'+], response. 
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FIG.  2. Effects  of  removing  external Ca2+ on the  acetvlcho- 
line-stimulated [Ca"Ii response. Fur;l"L-loaded C6'LH cells Lvere 
stimulated  with  acetvlcholine ( / \ ( ' \ I )  in the  presence o f  I . :?  m u  
external (:a'+ ( p a n d  A ) ,  rinsed, and allowed to recover for 'LO min. 
The  same  cells  were  then  switched  to  Cay+-tree  medium  with 0.5 m\l 
EGTA,  restimulated  with  acetylcholine.  finally  switched hack I O  
medium with 1.3 mM (:a'+ and acetylcholine at the times indirated 
( p o n d  8 ) .  [Ca"], values calculated from multiple experiments arts 
shown in pnncl C for various times in the stim~llated response a\ 
descrihed  in  Fig. 1 ;  the  response  in CaY'-free medium ( h n t r h d  h n n )  
is contrasted with previous data from Fig. 1 on the response in I . : \  
mM external Ca'+ (hlnnk  hnrs). l)ata in  Ca'+-free  media  are nverngcs 
+. S.E. of mean  responses  in five separate  experiments. 
min of acetylcholine addition. Replacing the Ca"-free me- 
dium with the original medium containing l.:? mM Ca2+ re- 
stored  the  sustained  [Cay+],  plateau  (Fig. 2; 3 min  after read- 
dition [Ca"], = 220 5 32 nM, n = 5). These results suggest 
that  mobilization of intracellular Ca" stores  accounts  for  the 
initial  peak  [Ca'+],  response,  whereas  the  sustained  elevation 
in [Ca"], is dependent  on  extracellular Ca" influx. T h e  two 
events appear to overlap to some extent: stimulated [Ca'*], 
levels a t  1 min  in Ca"-free medium  are  significantly  elevated 
over  basal  values  and  significantly  lower  than  in  the  presence 
of external Ca" ( p  < .Os). 
PDBu  Pretreatment  Inhibits Acet.vlchoIin~-stimr~latEd Ino- 
sitol Phosphate  Formation  and  Intracellular Ca" Rr4w.st with- 
out  Blocking Ca" Influx or Arachidonate  Liberation-We have 
demonstrated  previously  that  PDBu  pretreatment  effectively 
inhibits acetylcholine-stimulated inositol phosphate forma- 
tion in C62B cells (37). We therefore tested the effects of 
PDBu  on  the  stimulated  [Ca'+],  response  in  cells  loaded  with 
fura-2.  Pretreatment  with 200 nM PDRu  for 20 min  inhibited 
the initial peak increase in [Ca'+], ( p  < 0.02) without suh- 
stantially  affecting  the  sustained  plateau  levels  (Fig. 3 ) .  Peak 
increases in [Ca'+], were inhibited by 83 2 4 5  ( n  = 5 )  in 
Ca')+-free medium and 67 k 11% ( n  = 6) in 1.3 mM external 
Ca". The  time  to  peak  response  was  also  delaved by PDHu 
pretreatment (Fig. 3), going from 6 2 1 to  19 t :i s in Ca"- 
free medium ( n  = 5) and from 10 f 1 to 18 2 5 s in the 
presence of external  Ca2+ ( n  = 6). Identical  PDRu  pretreat- 
ments on ['"Clarachidonate-labeled cells  had  no  effect  on 
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FIG. 3. Effects of phorbol dibutyrate pretreatment on the 
acetylcholine-stimulated [Ca2+Ii  response. Panel A ,  in  a typical 
experiment, C62B cells loaded with fura-2 were stimulated with 
acetylcholine ( A C h ) ,  washed, treated with 200 nM PDBu for 20 min, 
and then restimulated with acetylcholine. The two responses have 
been superimposed with the same time for agonist addition as indi- 
cated. Panel B, calculated [Ca2+Ii values from multiple experiments 
are shown at  the peak of the response in Ca2+-free medium (peak) 
and  at 5 min after acetylcholine addition in 1.3 mM external Ca2+ 
(plateau), in the presence (solid bars) or absence (blank bars) of 
PDBu pretreatment. The  data are means * S.E. of control and  treated 
responses from the same cells in five or six separate  experiments  in 










FIG. 4. Effects of phorbol dibutyrate  pretreatment on ara- 
chidonic acid liberation. C62B cell cultures prelabeled with ["C] 
arachidonate were incubated for 20 min in the presence or absence 
of 200 nM PDBu and  then treated with acetylcholine (solid bars) or 
buffer (blank bars) for 90 s. Unesterified ['4C]arachidonic acid was 
assayed by TLC as described under "Methods." Each data value, 
presented as radioactivity/lane on the  TLC plate, is the mean f S.E. 
of three experiments performed in duplicate or triplicate. 
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FIG. 5. Effects of phorbol dibutyrate  pretreatment on ino- 
sitol phosphate formation and arachidonate liberation in dou- 
ble-labeled  C62B cells. Cell cultures were prelabeled with ["C] 
arachidonate and [3H]inositol for 24 h and  then treated with either 
buffer for 90 s (sample A ) ,  acetylcholine for 90 s (sample B ) ,  or 200 
nM phorbol dibutyrate for 20 min followed by acetylcholine for 90 s 
(sample C ) .  The cells were extracted, inositol phosphates in the 
aqueous phases were separated by HPLC, and arachidonic acid in the 
organic phases was separated from other lipids by TLC  as described 
under "Methods." HPLC traces (left) and TLC autoradiographs 
(right) are shown for each sample. Similar  results were obtained with 
two other sets of samples. GPZ, glycerophosphoinositol; ZP, inositol 
phosphate; ZP,, inositol bisphosphate. 
basal or acetylcholine-stimulated arachidonate liberation 
(Fig. 4, p > 0.5). As a control, C62B cells  were  double  labeled 
with ['4C]arachidonate and [3H]in~~itol   to all w assessment 
of inositol phosphate formation and arachidonate liberation 
in the same samples. PDBu pretreatment was found to inhibit 
agonist-stimulated inositol phosphate formation without al- 
tering arachidonate liberation (Fig. 5). Total inositol phos- 
phate formation was inhibited by 81 * 3% ( n  = 3) under these 
conditions. 
Ca2+ Influx Is Tightly Coupled to Acetylcholine-stimulated 
Arachidonute Liberati~n"['~C]Arachidonate labeling was 
used with the Ca2+-free medium protocol described  above to 
examine the role of extracellular Ca2+ in phospholipase A, 
activation. In the presence of external Ca2+, arachidonate 
accumulation peaks 60-90 s after acetylcholine addition and 
returns to basal values by 3 min (29). Switching C62B  cells 
to Ca2+-free medium with 0.5 mM EGTA 30 s prior to agonist 
addition completely  blocks stimulated arachidonate accumu- 
lation (Fig, 6, p < 0.001, n = 7 experiments performed in 
triplicate). If the inhibited cells are  then switched back to 
medium containing 1.3 mM Ca2+ to restore ca2+ influx (Fig. 
2), cholinergic arachidonate liberation is also  recovered  (Fig. 
6). Arachidonate accumulation at 3 min under these condi- 
tions was not significantly different from control 90-s stimu- 
lated levels ( p  > 0.5, n = 4 experiments performed in tripli- 
cate). Media switches alone had no  effect on basal arachidon- 
ate levels. 
Verapamil Pretreatment Inhibits Acetylcholine-stimulated 
Ca2+ Influx and Arachidonute Liberation without Affecting 
Intracellular Ca2+ Release-Verapamil, a voltage-dependent 
Ca2+ channel blocker (39, 40), was used to  test further  the 
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FIG. 6. Effects of external Ca2+ on acetylcholine-stimulated 
arachidonic acid liberation. Cultures of C62B cells prelabeled 
with ['4C]arachidonate were  incubated  with  acetylcholine (ACh) for 
the times indicated above in medium with 1.3 mM external Ca2+ 
(blank  bars), Ca2+-free medium with 0.5 mM EGTA (solid bars), or 
Ca2+-free medium  for 90 s followed  by a switch  with 1.3 mM external 
Caz+ (hatched  bar). Data for  unesterified  arachidonate  are  presented 
as in Fig. 4. Each value is the mean & S.E. of three to seven 
experiments  performed  in triplicate, with the number of experiments 
given in parentheses. Values indicated by asterisks are  significantly 
different from  all others at p < 0.001. The error  bars, which are shown 
for the raw data, are  smaller  when the values  are  normalized  within 
each  experiment. 
relationship between  Ca2+ influx  and phospholipase A2 acti- 
vation.  Pretreatment of fura-2 loaded  C62B cells with 250 pM 
verapamil for 20-30 min  inhibited  the  influx-dependent  pla- 
teau  phase of the  acetylcholine-stimulated  [Ca2+Ii response 
( p  < 0.05) without  altering  initial  peak [Ca2+Ii levels (Fig. 7 ) .  
The  resulting  [Ca2+Ii response  resembles that  obtained  in  the 
absence of extracellular Ca2+, with a return to basal levels 
within 2 min of agonist  addition (Figs. 7 B  and  2C).  Pretreat- 
ment of ['4C]arachidonate-labeled cells under  similar condi- 
tions produced a corresponding  inhibition of acetylcholine- 
stimulated  arachidonate  liberation (Fig. 8, p < 0.001). 
DISCUSSION 
Acetylcholine  Produces a Biphasic [Ca"Ii Response-Mus- 
carinic  stimulation of C62B rat glioma cells produces a bi- 
phasic [Ca'+Ii response,  a rapid  peak  in  [Ca2+Ii followed by a 
sustained elevation, similar  to  that  seen  in  other  systems  with 
receptors coupled to  phospholipase C (3, 41). The two phases 
of the response have been linked to the mobilization of 
intracellular  Caz+  stores  and  the  opening of plasma  membrane 
Ca2+  channels, respectively (3, 6), and  our  data  support  this 
interpretation. A temporal  comparison of acetylcholine-stim- 
ulated  changes  in [Ca"], and  arachidonate  accumulation does 
not  support  the idea that  phospholipase A2 activity  in C62B 
cells is regulated solely by changes  in overall  cytoplasmic Ca2+ 
levels. Although [Ca2+Ii  peaks  within 10 s of agonist  stimula- 
tion  and  then declines to a sustained  plateau level after  about 
1 min (Fig. I), arachidonate  accumulation  has been shown  to 
increase slowly over the  first  min  and  peak  at 60-90 s (29). 
Furthermore,  [Ca2+],  remains elevated  in the  continued  pres- 
ence of agonist and  external  Ca2+, whereas  phospholipase A2 
activation is a transient event under these conditions with 
arachidonate levels returning  to baseline by 3 min (29). 
Phorbol Dibutyrate  Inhibits  the  Intracellular Ca2+ Response 
without Blocking Ca2+ Influx or Phospholipase A2 Activation- 
Internal  Caz+ release is believed to  result from the  binding of 
1,4,5-IP3 to specific intracellular receptors (3, 4, 7 ,  42), and 
the  time course of the intracellular Caz+ response in C62B 
" 
Pre Peak I 2 3 4  5 
Time in Stimulated Response (min) 
FIG. 7 .  Effects of verapamil pretreatment on the acetylcho- 
line-stimulated [Ca2+Ii response. Panel A ,  fura-2-loaded C62B 
cells  were stimulated with  acetylcholine (ACh) in the presence of 1.3 
mM external Ca2+, rinsed, treated with 250 p M  verapamil for 21.5 
min,  and  restimulated with  acetylcholine in the same  medium. The 
two responses are superimposed with the same time for agonist 
addition as indicated. Panel B,  [Caz+], values from multiple experi- 
ments  are shown for responses  before (blank  bars) and  after (hatched 
bars) verapamil treatment. Data  are  presented  as in Fig. 1; the values 
are means & S.E. of control and treated responses from the same 
cells  in  four separate  experiments. 
2400 1 
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FIG. 8. Effects of verapamil pretreatment on arachidonic 
acid liberation. C62B cell cultures  prelabeled  with ['4C]arachidon- 
ate were incubated for 20-30 min in the presence or absence of 250 
p M  verapamil and then treated with acetylcholine (solid bars) or 
buffer (blank  bars) for 90 s. Unesterified  arachidonate was assayed, 
and the data are  presented  as in Fig. 4; each value is the mean & S.E. 
of three  experiments  performed in triplicate. 
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cells (Fig. 2) is consistent with changes in 1,4,5-IP3 levels 
determined previously (31). PDBu  is  an effective inhibitor of 
acetylcholine-stimulated  inositol  phosphate  formation  in 
C62B cells (37), and we therefore used PDBu to test the 
relationship  among inositol phosphate  formation,  intracellu- 
lar  Ca2+ release, and phospholipase A2 activation. As in  other 
systems (e.g. 43, 44),  pretreatment  with  PDBu  substantially 
inhibited  the peak stimulated  [Ca2+Ii response in C62B  cells 
(Fig. 3).  This result is probably  a direct  result of decreased 
1,4,5-IP3 formation since submaximal doses of agonist or 
1,4,5-IP3 have been  shown to produce corresponding  submax- 
imal increases in  [CaZ+Ii  and only fractional release of acces- 
sible internal Ca2+ stores (42). It is also possible, however, 
that  the phorbol ester may be affecting Ca2+ release at the 
level of the  1,4,5-IP3-operated  channel  (45).  The second phase 
of the [Ca2+It response was not substantially affected by 
PDBu, suggesting that Ca" influx is  far less sensitive  than 
intracellular Ca2+ release to stimulated changes in inositol 
phosphate levels. This  result may  reflect  regulation of Ca2+ 
influx by protein kinase C or G proteins (6, 46-48) rather 
than inositol phosphate metabolites (3, 7).  PDBu pretreat- 
ment also had  no effect on  stimulated  arachidonate  liberation 
under  conditions  that depressed inositol  phosphate  formation 
and  internal  Ca2+ release (Figs. 4 and  5),  demonstrating  that 
normal 1,4,5-IP3 production and [Ca2+Ii increases are not 
required for phospholipase A2 activation  in  the presence of 
normal  Ca2+ influx.  We cannot rule out  the possibility, how- 
ever, that a small amount of intracellular  Ca2+ release or a 
sustained elevation in  [Ca2+],  is required  for  phospholipase A2 
activation. Although PDBu  has been found  to increase basal 
and  stimulated  arachidonate  liberation  in  other  systems (17, 
18), it failed to  alter  these  parameters significantly in C62B 
cells. 
Ca2+ Influx Is Tightly Coupled to Phospholipase A2 Actiua- 
tion-Since PDBu did not block external Ca2+  influx or 
arachidonate  liberation,  it was possible that  such influx pro- 
vided the Ca2+  required  for  phospholipase A2 activation.  This 
hypothesis was tested by  assessing stimulated  arachidonate 
liberation  using  a  Ca2+-free  medium  protocol that was  shown 
to  inhibit  the  influx-dependent second phase of the  [Ca2+Ii 
response without  altering  peak  intracellular Ca2+  release (Fig. 
2). Acetylcholine-stimulated arachidonate  accumulation was 
totally  inhibited  under  such  conditions (Fig. 6),  demonstrating 
that Ca'+ influx is required  for phospholipase AS activation 
and, additionally,  showing that  normal  intracellular Ca2+ re- 
lease and  the resulting large changes  in  [Ca2+],  are  not suffi- 
cient  to  support phospholipase A2 activation.  Readdition of 
external Ca2+ to the inhibited cells restores not only Ca2+ 
influx  and  the  sustained  phase of the  [Ca2+Ii response (Fig. 2) 
but also stimulated  arachidonate  accumulation (Fig. 6),  rein- 
forcing the conclusion that Ca2+  influx is a  crucial event in 
phospholipase Az activation. In addition, this latter experi- 
ment suggests that  Ca2+ influx may be  involved  in the  timing 
of  the  transient  arachidonate signal;  delaying  Ca2+  influx  for 
90 s after agonist stimulation  results  in  arachidonate  libera- 
tion  at a time  (3  min) when the  normal response has  ended 
(29). 
Corroborative date  on  the  importance of external  Ca2+ in 
phospholipase Az activation were obtained using verapamil, 
an inhibitor of voltage-dependent Ca2+ channels (39, 40). 
Verapamil pretreatment produced a stimulated [Ca2+IL re- 
sponse similar to  that  obtained with Ca2+-free medium; the 
influx-dependent  phase of the response was blocked without 
affecting the peak intracellular Ca2+ release (Fig. 7). Once 
again,  these  alterations in the  [Ca2+], response were associated 
with  essentially quantitative  inhibition of acetylcholine-stim- 
ulated  arachidonate  accumulation (Fig. 8). Although verapa- 
mil is assumed  to be acting directly on  the  voltage-dependent 
Ca2+ channels  in  these  experiments  (39), we cannot  rule  out 
the possibility that  the dose used affects receptor-operated 
channels (49) or  indirectly  affects  the voltage-sensitive chan- 
nels by interfering  with Na' or K+ currents (40). 
The  present  results  can be explained by  a model for phos- 
pholipase A2 regulation in which the enzyme is  functionally 
associated with  plasma  membrane Ca2+ channels. Activation 
of phospholipase A2 may require Ca2+ influx in order to 
generate very  high  Ca2+ concentrations  in  the  microenviron- 
ment of the enzyme, as suggested for regulation of neurotrans- 
mitter release  (50).  Evidence exists  for localized membrane- 
associated increases  in [Ca2+Ii following muscarinic  stimula- 
tion of rat  parotid  acinar cells (51),  and  such a hypothesis 
would explain why many  phospholipase A2 enzymes  require 
millimolar Ca2+  concentrations for maximal  in vitro activation 
(e.g. 13, 25, 26). Phospholipase AP may be permanently  asso- 
ciated with the  membrane  near Ca2+ channels  or may bind to 
the  membrane  as a consequence of Ca2+ influx during  acti- 
vation (52). The Ca2+  released into  the cell from  sequestered 
intracellular  stores  is  assumed  to be functionally uncoupled 
from the enzyme by virtue of its location. 
This model is consistent  with  the observed phospholipase 
A2 requirement  for  extracellular Ca" in  other  systems (e.g. 
11,  17, 18). In  addition,  it may help  to  explain  the discrepancy 
between [Ca2+Ii changes and phospholipase A2 activation 
noted  with  different  agonists  in  platelets  (53),  and  the  recent 
demonstration of temperature-dependent dissociation of bra- 
dykinin-stimulated  1,4,5-IP3  and lysophosphatidylinositol 
formation  in  endothelial cells (54). Although it  does conflict 
with  experiments showing inhibition of arachidonate  libera- 
tion  with 8-(diethylamino)-octyl-3,4,5-trimethoxybenzoic 
acid (11, 28), an  inhibitor of intracellular  Ca2+ release ( 5 5 ) ,  
recent  studies  have  indicated  that  this  compound may block 
phospholipase AS in a Ca2+-independent  manner (19). Work 
by Balsinde et ~ l .  (56) in human neutrophils has suggested 
that cell compartmentalization may play a role in phospholi- 
pase Az regulation, demonstrating preferential ionophore- 
induced activation of the enzyme within  an  undefined  intra- 
cellular region. Interestingly, this same study found that 
plasma membrane-associatedphospholipase Ai! used phospha- 
tidylinositol preferentially  as  substrate,  as does the C62B cell 
enzyme  (31). 
We would stress  that  this model does not preclude  a coin- 
cident role for G proteins (10-12), protein  kinase C (16-19), 
lipocortins (20, 21), Na+/H+ exchange (22),  or  other  factors 
in  phospholipase Az regulation. In  fact,  since Ca2+  influx  does 
not desensitize in C62B  cells following acetylcholine stimu- 
lation  and  arachidonate  liberation does, one  or more of these 
factors may  be  responsible for terminating  the enzyme's  ac- 
tion in this system. Our results strongly suggest, however, 
that  Ca2+  influx  is required  for muscarinic  receptor  activation 
of phospholipase Az in  these cells. 
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